Can pulmonary embolism come back after treatment? 

A pulmonary embolism occurs when a blood vessel in the lung is blocked by a blood clot, often originating from the legs. While modern medical treatments are highly effective at managing an initial episode, many patients have concerns about whether the condition can return in the future. This article explores the likelihood of recurrence, the clinical factors that influence long-term risk, and the preventative strategies used by healthcare professionals in the UK to protect patients after their initial treatment. 

What We’ll Discuss in This Article 

• The clinical likelihood of a pulmonary embolism returning. 

• The difference in risk between provoked and unprovoked clots. 

• How long-term anticoagulant therapy reduces the chance of recurrence. 

• Permanent versus temporary risk factors for blood clots. 

• Warning signs that may indicate a new clotting event. 

• Lifestyle adjustments to help prevent future embolisms. 

The possibility of recurrent pulmonary embolism 

A pulmonary embolism can come back after treatment, particularly if the underlying cause or risk factor that triggered the first clot remains present or is permanent. Healthcare professionals in the UK categorise the risk of recurrence based on whether the original clot was “provoked” by a temporary event or “unprovoked.” According to the NHS, a pulmonary embolism can be life-threatening if it is not treated, and while treatment reduces the risk of further clots, some people may have a higher chance of it happening again. 

Understanding provoked vs unprovoked recurrence risks 

The risk of a pulmonary embolism returning is significantly lower if the first clot was provoked by a major temporary event that has since resolved. For example, if a clot occurred after major surgery or a leg fracture, the risk of it coming back once the patient is mobile again is generally low. Conversely, if a clot occurred without any obvious trigger, it is considered unprovoked, which suggests an ongoing or underlying tendency for the blood to clot, requiring more vigilant long-term management. 

Role of anticoagulants in preventing a return 

Anticoagulant medication is the most effective tool for preventing a pulmonary embolism from coming back by interrupting the body’s clotting process. NICE guidelines recommend that patients with an unprovoked pulmonary embolism should be offered long-term anticoagulant treatment to reduce the risk of a recurrence. By continuing medication beyond the initial three to six months, patients with permanent risk factors can significantly lower their chances of experiencing a second life-threatening event. 

Identifying permanent risk factors 

Certain individuals carry a higher risk of recurrent clots due to permanent biological or medical factors that cannot be easily changed. These include genetic conditions like thrombophilia, active cancer, or chronic inflammatory diseases. In these cases, the “trigger” for a clot is always present, which is why UK clinicians often recommend lifelong blood-thinning medication. Regular medical reviews are essential to balance the benefit of preventing a new clot against the potential risk of bleeding from long-term medication use. 

Type of Initial Clot	Example Trigger	Risk of Recurrence
Provoked (Major)	Major surgery, hip replacement.	Low once recovered.
Provoked (Minor)	Long-haul flight, hormone therapy.	Low to Moderate.
Unprovoked	No obvious cause.	Moderate to High.
Recurrent	History of previous clots.	Very High.

Recognising signs of a new embolism 

Even while on treatment or after finishing a course of medication, it is vital to remain aware of the symptoms that could indicate a new blood clot. A return of symptoms like sudden breathlessness, sharp chest pain that worsens with deep breathing, or unexplained coughing should be taken seriously. Because the risk of recurrence is never zero, healthcare providers focus on “safety-netting” advice, ensuring patients know exactly when to seek emergency help to prevent a minor event from becoming severe. 

Conclusion 

A pulmonary embolism can return, but the risk is managed through careful clinical assessment and appropriate use of preventative medication. The duration of treatment is tailored to whether the initial clot had a clear, temporary cause or an underlying, persistent one. Most patients can successfully avoid a recurrence by adhering to their treatment plan and maintaining regular follow-ups with their medical team. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This guide was created by the MyPatientAdvice Medical Content Team and reviewed by Dr. Stefan Petrov to provide accurate, evidence-based information for the public. The content is strictly aligned with the latest clinical pathways from the NHS and NICE regarding the management of venous thromboembolism. Our goal is to ensure readers understand the risks of recurrence and the standard UK medical practices for long-term prevention.